EXFORGE HCT

This brand name is authorized in United States. It is also authorized in Australia, Austria, Brazil, Croatia, Cyprus, Ecuador, Estonia, Finland, France, Hong Kong SAR China, Ireland, Lithuania, Mexico, Netherlands, New Zealand, Nigeria, Poland, Romania, Singapore, Spain, Tunisia.

Active ingredients

The drug EXFORGE HCT contains a combination of these active pharmaceutical ingredients (APIs):

1	Amlodipine UNII 864V2Q084H - AMLODIPINE BESYLATE
	Amlodipine is a calcium ion influx inhibitor of the dihydropyridine group (slow channel blocker or calcium ion antagonist) and inhibits the transmembrane influx of calcium ions into cardiac and vascular smooth muscle.
	Read more about Amlodipine
2	Valsartan UNII 80M03YXJ7I - VALSARTAN
	Valsartan is an orally active, potent, and specific angiotensin II (Ang II) receptor antagonist. It acts selectively on the AT1-receptor subtype, which is responsible for the known actions of angiotensin II.
	Read more about Valsartan
3	Hydrochlorothiazide UNII 0J48LPH2TH - HYDROCHLOROTHIAZIDE
	Hydrochlorothiazide is a diuretic with antihypertensive properties. It acts by inhibiting the renal tubular re-absorption of sodium and chloride ions, which are excreted with an accompanying volume of water. Potassium excretion is also promoted.
	Read more about Hydrochlorothiazide

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C09DX01	Valsartan, amlodipine and hydrochlorothiazide	C Cardiovascular system → C09 Agents acting on the renin-angiotensin system → C09D Angiotensin II antagonists, combinations → C09DX Angiotensin II antagonists, other combinations
Discover more medicines within C09DX01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	5285E, 5286F, 5287G, 5288H, 5289J
BR	Câmara de Regulação do Mercado de Medicamentos	526513030076804, 526513030077004, 526513030077104, 526513030077204, 526513030077404, 526513030077604, 526513030077704
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	1650-MEE-0116, 241-MEE-0414, 279-MEE-0514, 411-MEE-0814, 524-MEE-1114
EE	Ravimiamet	1440122, 1440133, 1440144, 1440155, 1440166, 1440177, 1440188, 1440199, 1440201, 1440212, 1440223, 1440234, 1440245, 1440256, 1440267, 1440278, 1440289, 1440290, 1440302, 1440313, 1440324, 1440335, 1440346, 1440357, 1440368, 1440379, 1440380, 1440391, 1440403, 1440414, 1440425, 1440436, 1440447, 1440458, 1440469
ES	Centro de información online de medicamentos de la AEMPS	09569002, 09569014, 09569026, 09569038, 109569050
FI	Lääkealan turvallisuus- ja kehittämiskeskus	055620, 055631, 055643, 055654, 055711, 055722
FR	Base de données publique des médicaments	61045063, 63945271, 64617605, 65369123
HK	Department of Health Drug Office	60136, 60137, 60138, 60139, 60140, 62221, 62222, 62223
IE	Health Products Regulatory Authority	14359, 14463, 14572, 14578, 14579, 32667, 32668
LT	Valstybinė vaistų kontrolės tarnyba	1051257, 1051258, 1051259, 1051260, 1051261, 1051262, 1051263, 1051264, 1051266, 1051267, 1051268, 1051269, 1051270, 1051271, 1051272, 1051273, 1051274, 1051275, 1051276, 1051277, 1051278, 1051279, 1051280, 1051281, 1051282, 1051283, 1051284, 1051285, 1051286, 1051287, 1051288, 1051289, 1051290, 1051291, 1051292, 1051293, 1051294, 1051295, 1051296, 1051297, 1051298, 1051299, 1051300, 1051301, 1051302, 1051303, 1051304, 1051305, 1051306, 1051307, 1051308, 1051309, 1051310, 1051311, 1051312, 1051313, 1051314, 1051315, 1051316, 1051317
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	200M2009
NG	Registered Drug Product Database	A4-5824, A4-5825, A4-5826, A4-5827, B4-1427
Switch country to Nigeria in order to find specific presentations of EXFORGE HCT
NL	Z-Index G-Standaard, PRK	123420, 123439, 123447, 123455, 123463
NZ	Medicines and Medical Devices Safety Authority	14529, 14530, 14531, 14532, 14533
PL	Rejestru Produktów Leczniczych	100094647, 100095150, 100101301, 100215750, 100224676
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W64768001, W64768002, W64768003, W64768004, W64768005, W64768006, W64768007, W64768008, W64768009, W64768010, W64768011, W64768012, W64769001, W64769002, W64769003, W64769004, W64769005, W64769006, W64769007, W64769008, W64769009, W64769010, W64769011, W64769012, W64770001, W64770002, W64770003, W64770004, W64770005, W64770006, W64770007, W64770008, W64770009, W64770010, W64770011, W64770012, W64771001, W64771002, W64771003, W64771004, W64771005, W64771006, W64771007, W64771008, W64771009, W64771010, W64771011, W64771012, W68729001, W68729002, W68729003, W68729004, W68729005, W68729006, W68729007, W68729008, W68729009, W68729010, W68729011, W68729012
SG	Health Sciences Authority	13898P, 13899P, 13900P, 13901P
TN	Direction de la Pharmacie et du Médicament	10283205, 10283206, 10283207, 10283208
US	FDA, National Drug Code	0078-0559, 0078-0560, 0078-0561, 0078-0562, 0078-0563